Transcriptome Analysis during Human Trophectoderm Specification Suggests New Roles of Metabolic and Epigenetic Genes by Assou, Said et al.
Transcriptome Analysis during Human Trophectoderm
Specification Suggests New Roles of Metabolic and
Epigenetic Genes
Said Assou
1,2., Ime `ne Boumela
1,2., Delphine Haouzi
1,C e ´cile Monzo
1,2, Herve ´ Dechaud
1,2,3, Issac-
Jacques Kadoch
4, Samir Hamamah
1,2,3*
1CHU Montpellier, Institute for Research in Biotherapy, Ho ˆpital Saint-Eloi, INSERM U1040, Montpellier, France, 2Universite ´ MONTPELLIER1, UFR de Me ´decine, Montpellier,
France, 3ART-PGD department, CHU Montpellier, Ho ˆpital Arnaud de Villeneuve, Montpellier, France, 4De ´partement d’Obste ´trique Gyne ´cologie, Universite ´ de Montre ´al,
Ho ˆpital Saint-Luc du CHUM, Montre ´al, Canada
Abstract
In humans, successful pregnancy depends on a cascade of dynamic events during early embryonic development.
Unfortunately, molecular data on these critical events is scarce. To improve our understanding of the molecular mechanisms
that govern the specification/development of the trophoblast cell lineage, the transcriptome of human trophectoderm (TE)
cells from day 5 blastocysts was compared to that of single day 3 embryos from our in vitro fertilization program by using
Human Genome U133 Plus 2.0 microarrays. Some of the microarray data were validated by quantitative RT-PCR. The TE
molecular signature included 2,196 transcripts, among which were genes already known to be TE-specific (GATA2, GATA3
and GCM1) but also genes involved in trophoblast invasion (MUC15), chromatin remodeling (specifically the DNA
methyltransferase DNMT3L) and steroid metabolism (HSD3B1, HSD17B1 and FDX1). In day 3 human embryos 1,714
transcripts were specifically up-regulated. Besides stemness genes such as NANOG and DPPA2, this signature included genes
belonging to the NLR family (NALP4, 5, 9, 11 and 13), Ret finger protein-like family (RFPL1, 2 and 3), Melanoma Antigen family
(MAGEA1, 2, 3, 5, 6 and 12) and previously unreported transcripts, such as MBD3L2 and ZSCAN4. This study provides a
comprehensive outlook of the genes that are expressed during the initial embryo-trophectoderm transition in humans.
Further understanding of the biological functions of the key genes involved in steroidogenesis and epigenetic regulation of
transcription that are up-regulated in TE cells may clarify their contribution to TE specification and might also provide new
biomarkers for the selection of viable and competent blastocysts.
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Introduction
Pre-implantation development of mammalian embryos encom-
passes a series of critical dynamic events, such as the transition
from a single-cell zygote to a multicellular blastocyst and the first
segregation of cells within the embryo with the formation of the
inner cell mass (ICM) surrounded by trophectoderm (TE) cells.
ICM retains pluripotency and gives rise to the embryo proper,
whereas TE cells play an important role in embryonic implanta-
tion in the uterine endometrium and placental formation. In
humans, the embryonic genome activation (EGA) program is
functional by day 3 after fertilization [1]. The 6–8 cell stage
embryo (day 3 post-fertilization) starts the process of ‘‘compaction’’
that leads to the generation of the tightly organized cell mass of the
morula and is followed by differentiation of the morula into a
blastocyst [2]. The transition from day 3 embryos to day 5
blastocysts is likely to be controlled by many and specific changes
in the expression of different genes as this process involves both
cellular differentiation and transcriptional reprogramming. Al-
though some genes that are specifically expressed in day 3 human
embryos and in TE cells, such as CCNA1 and GATA3 respectively
have been identified [3,4], our knowledge on the changes in gene
expression associated with the initial embryo-TE transition and
the specification of the TE cell lineage is still limited. In addition,
since TE biopsies from day 5 human blastocysts might become a
reliable alternative to blastomere biopsies to assess the expression
of biomarkers of embryo viability [5], a better knowledge of the
genes that are specifically expressed in TE cells and the embryo
proper is crucial. Recent technological advances in mRNA
amplification methods and DNA microarray assays have allowed
the simultaneous analysis of the transcript level of thousands of
genes in one experiment, thus offering a global view of the
molecular events regulating physiological functions and cellular
processes [6,7]. Indeed, these methodologies have already
contributed to improving our knowledge on the genetic network
controlling key stages of pre-implantation embryo development
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39306[8,9,10,11]. In this study, we used high-density oligonucleotide
Affymetrix HG-U133P microarray chips to analyze the gene
transcription profiles of single day 3 human embryos and TE cells
isolated from day 5 blastocysts. By comparing the transcriptomes
of TE cells and day 3 embryos, we identified the specific molecular
signature of human TE cells. These findings should provide a base
for investigating the molecular mechanisms of the embryo-TE
transition as well as important insights for the development of
diagnostic tests to test blastocyst quality in assisted reproduction
programs.
Results
Dynamic Changes in Overall Gene Expression in Mature
MII Oocytes, Single Day 3 Embryos, TE Cells from Day 5
Blastocysts and hESCs
In order to determine the global gene expression variation in the
different samples, we established the gene expression profile of
mature MII oocytes (n=3), day 3 single embryos (n=6), TE
samples from day 5 blastocysts (n=5) and hESCs (n=4) (to
represent the ICM) by using high-density oligonucleotide Affyme-
trix HG-U133P microarray chips. A non-supervised analysis using
the principal components analysis (PCA) showed that samples
from the same group clustered together very tightly (Figure 1A),
corroborating the robustness of the Affymetrix microarrays [12].
Moreover, a non-supervised hierarchical clustering analysis of the
array data (based on 15,000 genes) clustered perfectly the different
samples, confirming their very specific expression profiles
(Figure 1B). Finally, a scatter plot analysis (Figure S1) showed
that expression variations between mature MII oocytes and single
day 3 embryos were high as illustrated by the dispersed scatter
plots and the low correlation coefficient (0.51). Conversely, the
differences in gene expression between day 3 embryos and TE or
hESC samples were lower as indicated by the tighter scatter plots
and the high correlation coefficients (0.60–0.76) (Figure S1). These
results reveal dynamic transcriptome changes during the transition
from mature oocyte to day 3 embryo and from day 3 embryo to
blastocyst. These ‘‘dynamic patterns’’ are due to the large-scale
degradation of human maternal transcripts and the activation of
embryonic genes, as was also observed in the mouse [10,13].
Comparison of the Gene Expression Profiles of Day 3
Embryos and TE Cells Isolated from Day 5 Blastocysts
We then compared the expression profiles of day 3 embryos and
TE cells, by using the significance analysis of microarrays (SAM)
software with a 2-fold change cut-off and false discovery rate
(FDR) ,1%. We found that 2,196 transcripts were up-regulated in
human TE cells (‘‘TE molecular signature’’) and 1,714 in day 3
embryos (‘‘day 3 embryo molecular signature’’) (Figure 2). The
comprehensive lists of these signatures are presented in Tables S1
and S2 and the 100 genes with the highest fold change and
significant statistical value (FDR=0) for each signature are listed
in Table 1 and 2. The ‘‘day 3 embryo molecular signature’’
included the Developmental Pluripotency Associated gene 5
(DPPA5), members of the Ret finger protein-like gene family
(RFPL1, 2 and 3), of the NLR family (NALP4, 5, 9, 11 and 13), and
of the melanoma antigen family (MAGEA1, 2, 3, 5, 6 and 12).
Several maternal genes were found in this signature, such as
members of the Zona Pellucida gene family (ZP2, 3 and 4), ZAR1,
AURKC and FIGLA, suggesting that they are still active in day 3
embryos. Several transcription factors were also significantly over-
expressed in day 3 embryos, such as TFB1M and TFB2M, the
transcriptional regulators MBD3L2 and ZSCAN4, as well as
metabolic genes such as Pyruvate Dehydrogenase Kinase 3
(PDK3) and Lactate Dehydrogenases (LDHC). The ‘‘TE molecular
signature’’ comprised genes important for placental development
(PGF and TFAP2A), cytoskeleton-associated genes (Keratin 18 and
19), and genes encoding S100 calcium binding proteins (S100P,
S100A6, 10, 13, 14 and 16), retinoid receptor-related testis-
associated receptors (NR2F2 and NR2F6) or the B receptor
(CCKBR). Moreover, genes encoding extracellular matrix proteins,
such as Laminins (LAMA1, LAMA5 and LAMC1) and Integrins
(ITGB4 and ITGB5) were also up-regulated. Gene ontology (GO)
annotations were used to explore the specific functional properties
of the two molecular signatures (Figure 3). The day 3 embryo
molecular signature was enriched in genes associated with
localization in the ‘‘nucleus’’, while genes associated with the
‘‘cytoplasm’’ localization were over-represented in the TE
molecular signature. Concerning the ‘‘biological processes’’, the
day 3 embryo molecular signature was enriched in genes involved
in the regulation of cellular processes, transcription and post-
translational protein modifications. Conversely, in the TE
molecular signature, genes connected with different metabolic
and steroid biosynthetic processes were over-represented. The
‘‘molecular function’’ analysis showed that genes involved in
oxido-reductase activity were significantly enriched in the TE
signature (p,0.001), whereas genes related to ‘‘GTPase activity’’
and DNA binding were over-represented in the day 3 embryo
signature. Finally, the expression pattern of 11 genes belonging to
the TE (GATA3, LAMA1, KRT18, HSD3B1, HSD17B1 and
DNMT3L) or to the day 3 embryo molecular signature (MBD3L2,
CCNA1, BIK, RFPL2 and FIGLA) was confirmed by qRT-PCR
analysis using specific primer pairs (Table S3). All qRT-PCR data
were normalized to GAPDH to control for variations in mRNA
recovery and RT efficiency (Figure S2).
Expression of Genes Encoding Proteins which Play a Role
in Apoptosis in Day 3 Embryos and TE Samples
We then investigated the expression of genes coding for proteins
linked to the extrinsic and intrinsic apoptosis pathways in day 3
embryos and TE cells. The expression of genes of the TNF ligand
and receptor family was not different in day 3 embryos and TE
cells. Conversely, several genes belonging to the BCL-2, BIRC and
Caspase families appeared to be differentially expressed in the two
groups (Figure 4A). Specifically, the BCL-2 family members
BCL2L10 (637, FDR ,0.0001), BCL2L11 (616, FDR ,0.001),
and BIK (63.7, FDR ,0.001), the expression of which was
validated by qRT-PCR (Figure 3), and the BIRC family member
BIRC2 (64, FDR ,0.001) were up-regulated in day 3 embryos.
Caspase 6 (63, FDR ,0.001) was over-expressed in TE cells. MCL-
1, a gene that belongs to the BCL2 family and promotes cell
survival, was strongly expressed in both day 3 embryos and TE
samples.
Evaluation of DNA Repair Regulation in Day 3 Embryos
and TE Samples
The microarrays data were also used to investigate the
expression of a comprehensive list of DNA repair genes [14] in
day 3 embryos and TE samples (Tables S1 and S2). Of the 123
DNA damage repair genes investigated, five [UNG, RFC1, UNG2
(now named CCNO), PCNA, MSH2] were up-regulated in day 3
embryos and eleven [BRCA1, TDG, FANCG, FEN1, XRCC5,
XRCC6, XPC, MUTYH, XPA, SMUG1, POLD2] in TE cells. We
then analyzed the functional relationship between the DNA
damage repair genes that were differentially expressed in TE
samples and day 3 embryos using the Ingenuity Pathway Analysis
(IPA) software. In both cases, all the DNA repair genes displayed a
Transcriptome Analysis of Embryo and Trophectoderm
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tightly connected network (Figure S3).
Stemness Genes and Transcriptional Regulatory
Networks Identified in Day 3 Embryos and TE Cells
We then performed a stemness gene enrichment analysis using a
previously published dataset from hESCs, in which we defined a
consensus hESC stemness gene list (n=48 genes) [7]. The key
stemness factors NANOG, POU5F1 (OCT3/4) and SOX2 [15] were
enriched in day 3 human embryos, whereas DNMT3B, LIN28,
PHF17, SEPHS1 were over-represented in TE cells. Conversely,
other genes, such as UGP2 and PIM2, were enriched in both day 3
embryos and TE samples (Figure 4B). Bioinformatic gene pathway
analysis (Ingenuity software) of the day 3 embryo molecular
signature showed that many genes of the NANOG signaling
pathway, including NANOG (Figure 5), were up-regulated in day 3
human embryos, thus confirming the role of NANOG in the
maintenance of pluripotency [16]. The ‘‘TE molecular signature’’
included transcription factors such as GCM1, which is induced by
Transforming Growth Factor-b (TGF-b) [17], and Bone Morpho-
genic Protein 4 (BMP4) that induces the differentiation of
pluripotent stem cells to trophoblast cells [18,19]. Other compo-
nents of the TGF-b signaling cascade, such as Transforming
Growth Factor Beta Receptor III (TGFBRIII), were also included
in the ‘‘TE molecular signature’’.
Dynamic Expression of Epigenetic and Metabolic
Regulators During Trophoblast Development
Since specification of the TE lineage during blastocyst
formation involves initiation of differentiation, it is likely that
epigenetic regulators may have an important role in this first
developmental decision. The majority of the epigenetic regulators
that were up-regulated in TE cells are associated with a repressive
epigenetic status (Figure 5). Specifically, the expression of the DNA
methyl transferases (DNMT) DNMT3A, DNMT3B and DNMT1
increased between 2- and 13-fold in TE cells in comparison to day
3 embryos. DNMT3L expression was 70-fold higher in TE samples
than in day 3 embryos. Similarly, several transcripts coding for
proteins involved in chromatin remodeling and histone modifica-
tion (SMARCA4, SMARCC1 and SMARCE1) were up-regulated
between 2- and 7-fold in TE cells. Conversely, many histone
deacetylases (HDAC9and HDAC2) and histone acetyltransferases
(HAT1, SETD8, RNF20, TAF1, STK17B, 31, 32B and 35) were
down-regulated in TE cells in comparison to day 3 embryos.
Another feature of the TE molecular signature was the up-
regulation of several metabolic genes. Specifically, genes that are
involved in estrogen biosynthesis (CYP11A1 x35, CYP19A1 x14)
and lipid metabolism (PTGES x20) were strongly up-regulated in
TE cells. One of the most striking observations was the high
expression of genes that are involved in steroidogenesis (HSD3B1
6383, STS 6135, HSD17B1 6108, FDX1 614 and SRA1 66).
Figure 1. Gene expression patterns of day 3 human embryos, mature MII oocytes, TE cells and hESC cells. (A) PCA two-dimensional
scatter plots represent the differential gene expression patterns of the different human samples. Each dot represents a sample and the color its origin:
oocytes (green dots), day 3 embryos (blue dots), TE from day 5 embryos (black dots) and hESCs (red dots). Samples can be divided in four distinct
areas based on their gene expression. (B) Average-link hierarchical clustering of 15,000 genes delineated four major gene clusters: (a) genes
specifically detected in mature MII oocytes; (b) genes over-expressed in hESCs; (c) genes up-regulated in TE and (d) genes specifically over-expressed
in day 3 embryos.
doi:10.1371/journal.pone.0039306.g001
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Oocytes and hESCs
In an effort to link the genes involved in the day 3 embryo-TE
transition with early embryonic development, we further investi-
gated differences and similarities in the gene expression patterns of
MII oocytes, day 3 embryos, TE cells and hESCs samples
(comprehensive list in Table S4). The genes that were found to be
up-regulated in day 3 embryos (Table S1) and TE cells (Table S2)
were individually compared to those up-regulated in MII oocytes
and hESCs using Venn diagrams (Figure S4). Only 36 genes were
common to both the TE and the MII oocyte signatures. On the
other hand, day 3 embryos and MII oocytes shared a set of 511
genes, among which many are associated with oogenesis, such as
DAZL, GDF9 and FIGLA. Finally, 1263 genes were common to
both TE and hESC profiles, whereas only 124 genes were shared
by day 3 embryos and the hESCs. Genes that were up-regulated in
both TE and hESC samples were associated with cell death and
proliferation (BAG6, CASP2 and ANXA3), metabolism (GCDH and
HPGD) and WNT signaling (FZD5, AXIN1 and TCF3). Genes that
were up-regulated in both day 3 embryos and hESCs (124 genes)
are involved in the maintenance of pluripotency and tissue
development, such as NANOG. Among the genes specifically up-
regulated in TE samples (644 genes), key genes related to
epigenetic and metabolic pathways, such as DNMT3L, HSD3B1
and HSD17B1, were observed.
Discussion
Here, we compared the transcriptomes of day 3 human
embryos and TE cells from day 5 human blastocysts to identify
transcripts that are differentially expressed during the embryo-to-
TE transition and the specification of the TE cell lineage. Many of
the genes that were up-regulated in TE cells are already known to
be associated with human TE differentiation [20,21]. For instance,
we confirmed that GATA3 and KRT18, two trophoblast-determin-
ing genes, are enriched in TE from human blastocysts [22].
Moreover, the ‘‘TE molecular signature’’ included also unexpect-
ed genes, the TE-specificity of which has been overlooked. For
instance, CCKBR activates signaling pathways involved in cell
proliferation or migration [23,24] and stimulates the expression of
b1-Integrin in vitro [25]. A number of cell adhesion genes that
might be implicated in the embryo attachment to the endometri-
um were also up-regulated in TE cells, including members of the
Integrin family (ITGB5) and genes related to extracellular matrix
remodeling, such as Laminins (LAMA1 and LAMC1). In humans,
active steroid hormones, including progesterone that is secreted by
mouse TE cells [26], are essential for implantation and mainte-
nance of pregnancy. Our analysis reveals that HSD3B1, HSD17B1
and FDX1, which encode enzymes involved in the metabolism of
cholesterol, were specifically up-regulated in TE cells in compar-
ison to day 3 embryos (Figure S5). Moreover, PTGES (Prosta-
glandin E synthase) as well as CYP11A1 and CYP19A1 (estrogen
synthesis) were also up-regulated in TE cells, suggesting a central
role of these steroidogenic enzymes in TE steroid biosynthesis and
Figure 2. Day 3 embryo and TE molecular signatures: Heat map of the molecular signatures in six day 3 embryos and five TE samples. Each
horizontal line represents a gene and each column represents a single sample. The color intensity indicates the level of gene expression (red for up-
regulation and blue for down-regulation) ‘‘see also Table S1 and S2’’.
doi:10.1371/journal.pone.0039306.g002
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‘‘steroidogenic’’ activity, such as brain, heart, gonads, endometri-
um and placenta [27,28]. It is now important to compare the
steroidogenic gene expression profiles in TE cells isolated from
good and bad quality blastocysts to fully correlate specific
transcriptional events with efficient TE development.
Among the models used to study trophoblast development,
hESCs have emerged as a useful tool to examine the emergence
and differentiation of TE cells. Particularly, the transcriptomic
analysis of TE cells derived from hESCs has provided new insights
into the signaling pathways and the molecular mechanisms
underlying early trophoblast development. Recently, by using a
microarray approach, Marchand and colleagues investigated gene
expression during differentiation of hESCs into the trophoblast
lineage upon addition of Bone Morphogenetic Protein 4 (BMP4)
for 10 days and identified 670 genes that were up-regulated from
day 0 to day 10 [29]. By intersecting these genes with those we
found to be up-regulated in TE cells isolated from day 5 embryos,
we found 104 common genes (see Table S5) among which there
were not only trophoblast markers (for instance, GATA3 and
KRT19), but also many genes implicated in lipid metabolism and
estrogen biosynthesis (i.e., CYP19A1, CYP11A1, HSD17B1,
HSD3B1, PTGES, STS, HPGD, SLCO2A1, HMOX1, ABCG2,
ASAH1 and SMPD1). This finding validates the importance of
metabolic genes during TE specification. Aghajanova et al. [30]
compared the transcriptome of embryo-derived TE cells with that
of hESC-derived TE cells and found that most of the shared genes
were involved in the development of receptive endometrium
during implantation. Suzuki et al. [31] used human embryonic
carcinoma cells (G3), which can differentiate into TE cells, as an
experimental model to investigate the molecular mechanism of
trophoectoderm differentiation. Thus, comparative studies using
human TE and hESC or G3 cells are relevant to better understand
the molecular basis of cell fate decisions and to develop models of
human TE development.
The ‘‘day 3 embryo molecular signature’’ was enriched in genes
from the NLRP (named NALP) family which might play a role in
early embryo development [32,33]. Indeed, NLRP5, NLRP8 and
NLRP9 are expressed in bovine and human pre-implantation
embryos [32,34] and, in pregnant NLRP5 null female mice,
Figure 3. Gene Ontology (GO) annotations of the day 3 embryo and TE molecular signatures. We compared the GO annotations of genes
specifically over-expressed in day 3 embryos and in TE cells by using the Babelomics web tool (http://babelomics.bioinfo.cipf.es/). Histograms show
the percentage of genes with a specific GO annotation in day 3 embryos (white) or in TE samples (black). Only GO categories which differed
significantly (p value ,0.01) between the two groups are shown.
doi:10.1371/journal.pone.0039306.g003
Transcriptome Analysis of Embryo and Trophectoderm
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e39306Table 1. List of the 100 genes with the highest fold change in day 3 human embryos in comparison to TE samples.
Probesets Gene Name Gene Title UniGene
Chromosomal
Location
Fold
change FDR (%)
1552531_a_at NALP11 NLR family, pyrin domain containing 11 Hs.375039 chr19q13.42 1893 0
242334_at NALP4 NLR family, pyrin domain containing 4 Hs.631533 chr19q13.42 892 0
214957_at ACTL8 actin-like 8 Hs.2149 chr1p36.2-p35 755 0
1556096_s_at UNC13C unc-13 homolog C Hs.443456 chr15q21.3 663 0
207443_at NR2E1 nuclear receptor subfamily 2, group E, member 1Hs.157688 chr6q21 625 0
1553619_a_at TRIM43 tripartite motif-containing 43 Hs.589730 chr2q11.1 519 0
1552405_at NALP5 NLR family, pyrin domain containing 5 Hs.356872 chr19q13.42 448 0
209160_at AKR1C3 aldo-keto reductase family 1, member C3 Hs.78183 chr10p15-p14 431 0
1552456_a_at MBD3L2 methyl-CpG binding domain protein 3-like 2 Hs.567667 chr19p13.2 394 0
1557085_at TMEM122 placenta-specific 1-like Hs.132310 chr11q12.1 387 0
39318_at TCL1A T-cell leukemia/lymphoma 1A Hs.2484 chr14q32.1 342 0
234393_at HDAC9 histone deacetylase 9 Hs.196054 chr7p21.1 315 0
1552912_a_at IL23R interleukin 23 receptor Hs.200929 chr1p31.3 306 0
1552852_a_at ZSCAN4 zinc finger and SCAN domain containing 4 Hs.469663 chr19q13.43 282 0
226117_at TIFA TRAF-interacting protein with a forkhead-
associated domain
Hs.310640 chr4q25 275 0
222361_at LOC643224 similar to tubulin, beta 8 Hs.551805 chr9q34.3 273 0
229105_at GPR39 G protein-coupled receptor 39 Hs.432395 chr2q21-q22 255 0
225626_at PAG1 phosphoprotein associated with
glycosphingolipid microdomains 1
Hs.266175 chr8q21.13 230 0
1557544_at C10orf80 chromosome 10 open reading frame 80 Hs.253576 chr10q25.1 209 0
210634_at KLHL20 kelch-like 20 (Drosophila) Hs.495035 chr1q24.1-q24.3 206 0
206343_s_at NRG1 neuregulin 1 Hs.453951 chr8p21-p12 184 0
207213_s_at USP2 ubiquitin specific peptidase 2 Hs.524085 chr11q23.3 182 0
1563120_at Hs.623820 Homo sapiens, clone IMAGE:5528155, mRNA Hs.630724 175 0
237131_at LOC645469 hypothetical protein FLJ36032 Hs.297967 chr1q21.3 172 0
221630_s_at DDX4 DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 Hs.223581 chr5p15.2-p13.1 171 0
241550_at DPPA5 developmental pluripotency associated 5 Hs.125331 chr6q13 167 0
217365_at PRAMEF5 similar to PRAME family member 6 chr1p36.21 157 0
1570337_at FIGLA folliculogenesis specific basic helix-loop-helix Hs.407636 chr2p13.3 157 0
206140_at LHX2 LIM homeobox 2 Hs.445265 chr9q33-q34.1 154 0
229738_at DNAH10 dynein, axonemal, heavy chain 10 Hs.622654 chr12q24.31 154 0
209785_s_at PLA2G4C phospholipase A2, group IVC (cytosolic, calcium-
independent)
Hs.631562 chr19q13.3 149 0
237613_at FOXR1 forkhead box R1 Hs.116679 chr11q23.3 147 0
236914_at AW080028 137 0
210467_x_at MAGEA12 melanoma antigen family A, 12 chrXq28 137 0
242128_at OTX2 orthodenticle homolog 2 (Drosophila) Hs.288655 chr14q21-q22 128 0
220535_at FAM90A1 family with sequence similarity 90, member A1 Hs.196086 chr12p13.31 128 0
215048_at SUHW2 suppressor of hairy wing homolog 2 (Drosophila)Hs.43834 chr22q11.22 127 0
207934_at RFPL1 ret finger protein-like 1 Hs.648249 chr22q12.2 127 0
209994_s_at ABCB1 ATP-binding cassette, sub-family B (MDR/TAP),
member 1
Hs.489033 chr7q21.1 125 0
207227_x_at RFPL2 ret finger protein-like 2 Hs.157427 chr22q12.3 116 0
238218_at LOC648473 hypothetical protein LOC648473 112 0
214603_at MAGEA2 melanoma antigen family A, 2 Hs.169246 chrXq28 111 0
217590_s_at TRPA1 transient receptor potential cation channel,
subfamily A, member 1
Hs.137674 chr8q13 110 0
208312_s_at PRAMEF1 PRAME family member 1 Hs.104991 chr1p36.21 109 0
223866_at ARMC2 armadillo repeat containing 2 chr6q21 106 0
216001_at LOC390999 PRAME family member 12 Hs.156406 chr1p36.21 106 0
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Probesets Gene Name Gene Title UniGene
Chromosomal
Location
Fold
change FDR (%)
213228_at PDE8B phosphodiesterase 8B Hs.584830 chr5q14.1 104 0
1552807_a_at SIGLEC10 sialic acid binding Ig-like lectin 10 Hs.284813 chr19q13.3 104 0
236205_at Hs.13188 similar to ATP-binding cassette, sub-family C,
member 6
Hs.13188 chr16p12.3 104 0
209942_x_at MAGEA3 melanoma antigen family A, 3 Hs.417816 chrXq28 100 0
226271_at GDAP1 ganglioside-induced differentiation-associated
protein 1
Hs.168950 chr8q21.11 98 0
240031_at AA994467 Baculoviral IAP repeat-containing 2 Hs.503704 chr11q22 98 0
209570_s_at D4S234E DNA segment on chromosome 4 (unique) 234
expressed sequence
Hs.518595 chr4p16.3 98 0
206207_at CLC Charcot-Leyden crystal protein Hs.889 chr19q13.1 96 0
230626_at TSPAN12 tetraspanin 12 Hs.16529 chr7q31.31 93 0
216034_at SUHW1 suppressor of hairy wing homolog 1 (Drosophila)Hs.178665 chr22q11.22 89 0
231756_at ZP4 zona pellucida glycoprotein 4 Hs.136241 chr1q43 89 0
202388_at RGS2 regulator of G-protein signalling 2, 24 kDa Hs.78944 chr1q31 85 0
205747_at CBLN1 cerebellin 1 precursor Hs.458423 chr16q12.1 84 0
230753_at LOC197135 hypothetical LOC197135 Hs.11594 chr15q21.1 83 0
236117_at Hs.42747 Transcribed locus Hs.42747 83 0
1556834_at Hs.562766 CDNA clone IMAGE:5296106 Hs.562766 83 0
209278_s_at TFPI2 tissue factor pathway inhibitor 2 Hs.438231 chr7q22 81 0
240318_at AFMID Arylformamidase Hs.558614 chr17q25.3 80 0
1557257_at BCL10 B-cell CLL/lymphoma 10 Hs.193516 chr1p22 80 0
236504_x_at C6orf52 chromosome 6 open reading frame 52 Hs.61389 chr6p24.1 80 0
204438_at MRC1 mannose receptor, C type 1 Hs.75182 chr10p12.33 80 0
1559108_at VPS53 Vacuolar protein sorting 53 (S. cerevisiae) Hs.461819 chr17p13.3 79 0
210180_s_at SFRS10 splicing factor, arginine/serine-rich 10
(transformer 2 homolog, Drosophila)
Hs.533122 chr3q26.2-q27 77 0
214960_at API5 apoptosis inhibitor 5 Hs.435771 chr11p12-q12 77 0
232692_at TDRD6 tudor domain containing 6 Hs.40510 chr6p12.3 76 0
240731_at LOC441316 76 0
230697_at BBS5 Bardet-Biedl syndrome 5 Hs.233398 chr2q31.1 75 0
244206_at ANUBL1 AN1, ubiquitin-like, homolog (Xenopus laevis) Hs.89029 chr10q11.21 75 0
222921_s_at HEY2 hairy/enhancer-of-split related with YRPW motif 2Hs.144287 chr6q21 74 0
1557146_a_at FLJ32252 hypothetical protein FLJ32252 Hs.250557 chr16p13.3 73 0
241382_at PCP4L1 Purkinje cell protein 4 like 1 Hs.433150 chr1q23.3 73 0
226811_at FAM46C family with sequence similarity 46, member C Hs.356216 chr1p12 73 0
44783_s_at HEY1 hairy/enhancer-of-split related with YRPW motif 1Hs.234434 chr8q21 73 0
239061_at TPRXL tetra-peptide repeat homeobox-like Hs.638296 chr3p25.1 72 0
223562_at PARVG parvin, gamma Hs.565777 chr22q13.2-q13 69 0
219352_at HERC6 hect domain and RLD 6 Hs.529317 chr4q22.1 69 0
1553697_at C1orf96 chromosome 1 open reading frame 96 Hs.585011 chr1q42.13 68 0
1568924_a_at FLJ35834 hypothetical protein FLJ35834 Hs.159650 chr7q31.32 68 0
221314_at GDF9 growth differentiation factor 9 Hs.25022 chr5q31.1 67 0
228737_at C20orf100 chromosome 20 open reading frame 100 Hs.26608 chr20q13.12 66 0
240070_at VSIG9 V-set and immunoglobulin domain containing 9 Hs.421750 chr3q13.31 66 0
231448_at Tenr testis nuclear RNA-binding protein Hs.518957 chr4q27 65 0
214612_x_at MAGEA6 melanoma antigen family A, 6 Hs.441113 chrXq28 64 0
206696_at GPR143 G protein-coupled receptor 143 Hs.74124 chrXp22.3 62 0
205551_at SV2B synaptic vesicle glycoprotein 2B Hs.592018 chr15q26.1 61 0
219686_at STK32B serine/threonine kinase 32B Hs.133062 chr4p16.2-p16.1 61 0
Transcriptome Analysis of Embryo and Trophectoderm
PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e39306embryo development is arrested at the two-cell stage [35].
Remarkably, many genes of the day 3 signature belong to the
Melanoma Antigen family and the Ret finger protein-like family.
Most of their functions remain largely unknown, but some of them
are thought to regulate, respectively, placenta and early embryo
development [36,37]. Mouse data suggest that two other day 3
embryo-specific genes (MBD3L2 and ZSCAN4) might regulate
early embryo development. In mouse embryos, MBD3L2 expres-
sion coincides with EGA [38] and ZSCAN4 (zinc finger and SCAN
domain containing 4) is important for the progression from the 2-
cell to 4-cell stage [39]. ZSCAN4 plays also a key role in defying
cellular senescence and maintaining a normal karyotype during
propagation of embryonic stem cells in culture [40]. Additionally,
the expression levels of DPPA5, DPPA2 and the stemness factor
NANOG were much higher in day 3 embryos than in TE samples.
The reciprocal pattern of expression of Nanog and the transcription
factors Gata6 and Cdx2 in the mouse morula suggests that Nanog
might determine ICM pluripotency by repressing Gata6 and Cdx2,
which are implicated in the extra-embryonic lineage specification
[41].
Our transcriptome analysis also shows that the TE molecular
signature includes many genes that are annotated as ‘‘membrane’’,
demonstrating a strong bias towards genes involved in cell-to-cell
communication processes. Conversely, genes specifically expressed
by day 3 embryos are largely ‘‘nuclear’’. Additionally, we
categorized the genes that were up-regulated during the MII-day
3 transition according to their molecular and cellular function
using the GO annotations and found that they were mainly
associated with nuclear localization. This is in line with previously
published data showing that proteins produced by the most up-
regulated genes during the MII-day 2 embryo transition are
mainly localized in the nucleus [11] and that hESC-specific genes
are significantly depleted in extracellular signaling components
[7]. One assumption that can be inferred from these findings is
that the determinants of the MII-embryo transition and pluripo-
tency may be regulated by intrinsic factors.
Apoptotic cell death has been observed in human and other
mammalian pre-implantation embryos [42]. The expression
profile of apoptosis-related genes in day 3 embryos suggests that
the balance between anti- (BCL2L10 and BIRC2) and pro-
apoptotic factors (BCL2L11 and BIK) might be critical at this
stage of development. As the onset of EGA occurs at day 3 post-
fertilization in humans, embryos that fail to accurately activate
their genome might be committed to death by default. In contrast
to mouse blastocysts where apoptosis occurs predominantly in
ICM cells [43], apoptotic nuclei have been detected in both ICM
and TE cells in human blastocysts [44]. Accordingly, we show that
some molecular actors of apoptosis signaling are up-regulated in
human TE cells (i.e. Caspase 6, MCL-1).
The expression of some DNA repair genes has been detected in
mammalian embryos at different stages of development [45]. Our
data show that two ‘‘DNA damage sensor’’ genes (RFC1 and
PCNA1) and two ‘‘base excision repair’’ genes (UNG and UNG2
(now named as CCNO)) are up-regulated in human day 3 embryos,
in line with previous works [46], and three ‘‘Double strand break
repair’’ genes (BRCA1, XRCC5 and XRCC6) are over-expressed in
TE cells. In homozygous Brca1
5–6 mouse mutants, in which exons
5 and 6 of Brca1 were deleted, the development of the extra-
embryonic region was abnormal and diploid trophoblast cells were
absent [47]. This may indicate that the ‘‘Double strand break
repair’’ activity may be important for TE specification.
Epigenetic mechanisms, including DNA methylation, are key
elements for controlling gene expression during the embryo-TE
transition. In mouse blastocysts, DNA methyltransferase expres-
sion is restricted to the ICM, in which nuclei are highly methylated
[48], whereas in human and bovine blastocysts, DNA methylation
is higher in TE than ICM cells [49]. Here we report a strong
expression of DNA (cytosine-5) methyltransferases (DNMT3A,
DNMT3B, DNMT1 and DNMT3L) in human TE cells (Figure 5).
DNMT3A and DNMT3B are de novo enzymes that establish
methylation patterns. DNMT1 is a maintenance enzyme involved
in preserving already acquired methylation patterns. DNMT3L
lacks a catalytic domain, but can interact with the de novo
enzymes [50], stimulating their activity [51]. Comparison with
other samples including MII oocytes and hESCs suggests that
DNMT3L is specifically up-regulated in TE cells (Figure S4).
However, DNA methylation levels have been described to be
globally low in extra-embryonic tissues in both mouse and human
embryos [52,53]. In these tissues, DNA (cytosine-5) methyltrans-
ferases enzymes are expressed only transiently and do not
contribute to adult tissues maintenance, thus long-term epigenetic
reprogramming may not be critical for extra-embryonic tissues.
Moreover, the high expression of different epigenetic regulators in
human TE cells could be a consequence of in vitro embryo culture.
Studies in animal models have demonstrated that under certain in
vitro culture conditions, DNA methylation profiles can be altered
[54]. In another hand, the association between in vitro culture
conditions during assisted reproduction and increased risk of some
epigenetic disorders has been reported, clearly indicating that
epigenetic deregulation must be considered when examining in
Table 1. Cont.
Probesets Gene Name Gene Title UniGene
Chromosomal
Location
Fold
change FDR (%)
230645_at FRMD3 FERM domain containing 3 Hs.127535 chr9q21.32 60 0
1555396_s_at LOC340602 similar to CG32656-PA Hs.97053 chrXp11.22 59 0
237464_at IMAA SLC7A5 pseudogene Hs.448808 chr16p12.2 58 0
212158_at SDC2 syndecan 2 (heparan sulfate proteoglycan 1, cell
surface-associated, fibroglycan)
Hs.1501 chr8q22-q23 57 0
220657_at KLHL11 kelch-like 11 (Drosophila) Hs.592134 chr17q21.2 57 0
223883_s_at STK31 serine/threonine kinase 31 Hs.309767 chr7p15.3 57 0
222925_at DCDC2 doublecortin domain containing 2 Hs.61345 chr6p22.1 56 0
210148_at AF305239 homeodomain interacting protein kinase 3 Hs.201918 chr11p13 56 0
doi:10.1371/journal.pone.0039306.t001
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Probesets Gene Name Gene Title UniGene
Chromosomal
Location
Fold
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205980_s_at ARHGAP8 Rho GTPase activating protein 8/PRR5-ARHGAP8
fusion
chr22q13.31 514 0
218237_s_at SLC38A1 solute carrier family 38, member 1 Hs.533770 chr12q13.11 469 0
201596_x_at KRT18 keratin 18 Hs.406013 chr12q13 445 0
204515_at HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3
beta- and steroid delta-isomerase 1
Hs.364941 chr1p13.1 383 0
227048_at LAMA1 laminin, alpha 1 Hs.270364 chr18p11.31 372 0
34260_at KIAA0683 TEL2, telomere maintenance 2, homolog (S.
cerevisiae)
Hs.271044 chr16p13.3 361 0
224348_s_at AF116709 341 0
223168_at RHOU ras homolog gene family, member U Hs.647774 chr1q42.11-q42.3 310 0
204158_s_at TCIRG1 T-cell, immune regulator 1, ATPase, H+
transporting, lysosomal V0 subunit A3
Hs.495985 chr11q13.2 283 0
212203_x_at IFITM3 interferon induced transmembrane protein 3
(1–8 U)
Hs.374650 chr11p15.5 279 0
242705_x_at Hs.592928 Full length insert cDNA clone YT86E01 Hs.592928 277 0
204351_at S100P S100 calcium binding protein P Hs.2962 chr4p16 262 0
201650_at KRT19 keratin 19 chr17q21.2 260 0
229125_at ANKRD38 ankyrin repeat domain 38 Hs.283398 chr1p31.3 238 0
224646_x_at H19 H19, imprinted maternally expressed
untranslated mRNA
Hs.533566 chr11p15.5 208 0
221538_s_at PLXNA1 plexin A1 Hs.432329 chr3q21.3 204 0
210381_s_at CCKBR cholecystokinin B receptor Hs.203 chr11p15.4 196 0
217853_at TNS3 tensin 3 Hs.520814 chr7p12.3 194 0
209771_x_at CD24 CD24 molecule Hs.644105 chr6q21 194 0
210201_x_at BIN1 bridging integrator 1 Hs.193163 chr2q14 156 0
224579_at Hs.592612 solute carrier family 38, member 1 Hs.533770 chr12q13.11 147 0
204720_s_at DNAJC6 DnaJ (Hsp40) homolog, subfamily C,
member 6
Hs.647643 chr1pter-q31.3 135 0
212444_at Hs.632997 CDNA clone IMAGE:6025865 Hs.632997 135 0
203767_s_at STS steroid sulfatase (microsomal), arylsulfatase C,
isozyme S
Hs.522578 chrXp22.32 135 0
215729_s_at VGLL1 vestigial like 1 (Drosophila) Hs.496843 chrXq26.3 134 0
227241_at MUC15 mucin 15, cell surface associated Hs.407152 chr11p14.3 133 0
204121_at GADD45G growth arrest and DNA-damage-inducible,
gamma
Hs.9701 chr9q22.1-q22.2 125 0
212077_at CALD1 caldesmon 1 Hs.490203 chr7q33 122 0
201787_at FBLN1 fibulin 1 Hs.24601 chr22q13.31 121 0
202286_s_at TACSTD2 tumor-associated calcium signal transducer 2 Hs.23582 chr1p32-p31 109 0
218571_s_at CHMP4A chromatin modifying protein 4A Hs.279761 chr14q12 108 0
205829_at HSD17B1 hydroxysteroid (17-beta) dehydrogenase 1 Hs.50727 chr17q11-q21 108 0
205093_at PLEKHA6 pleckstrin homology domain containing,
family A member 6
Hs.253146 chr1q32.1 105 0
209735_at ABCG2 ATP-binding cassette, sub-family G (WHITE),
member 2
Hs.480218 chr4q22 104 0
213050_at COBL cordon-bleu homolog (mouse) Hs.99141 chr7p12.1 97 0
205081_at CRIP1 cysteine-rich protein 1 (intestinal) Hs.122006 chr14q32.33 93 0
209262_s_at NR2F6 nuclear receptor subfamily 2, group F,
member 6
Hs.466148 chr19p13.1 91 0
203438_at STC2 stanniocalcin 2 Hs.233160 chr5q35.2 90 0
214285_at FABP3 fatty acid binding protein 3, muscle and heart Hs.584756 chr1p33-p32 89 0
209369_at ANXA3 annexin A3 Hs.480042 chr4q13-q22 89 0
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209723_at SERPINB9 serpin peptidase inhibitor, clade B (ovalbumin),
member 9
Hs.104879 chr6p25 88 0
209921_at SLC7A11 solute carrier family 7, (cationic amino acid
transporter, y+ system) member 11
Hs.390594 chr4q28-q32 87 0
216604_s_at SLC7A8 solute carrier family 7 (cationic amino acid
transporter, y+ system), member 8
Hs.632348 chr14q11.2 86 0
228949_at GPR177 G protein-coupled receptor 177 Hs.647659 chr1p31.3 84 0
202007_at NID1 nidogen 1 Hs.356624 chr1q43 84 0
209513_s_at HSDL2 hydroxysteroid dehydrogenase like 2 Hs.59486 chr9q32 83 0
225520_at MTHFD1L methylenetetrahydrofolate dehydrogenase
(NADP+ dependent) 1-like
Hs.591343 chr6q25.1 82 0
202023_at EFNA1 ephrin-A1 Hs.516664 chr1q21-q22 81 0
205710_at LRP2 low density lipoprotein-related protein 2 Hs.470538 chr2q24-q31 78 0
217764_s_at RAB31 RAB31, member RAS oncogene family Hs.99528 chr18p11.3 77 0
225516_at SLC7A2 solute carrier family 7 (cationic amino acid
transporter, y+ system), member 2
Hs.448520 chr8p22-p21.3 77 0
200832_s_at SCD stearoyl-CoA desaturase (delta-9-desaturase) Hs.558396 chr10q23-q24 76 0
202418_at YIF1A Yip1 interacting factor homolog A (S. cerevisiae) Hs.446445 chr11q13 74 0
200872_at S100A10 S100 calcium binding protein A10 Hs.143873 chr1q21 74 0
209603_at GATA3 GATA binding protein 3 Hs.524134 chr10p15 73 0
1555832_s_at KLF6 Kruppel-like factor 6 Hs.4055 chr10p15 73 0
202737_s_at LSM4 LSM4 homolog, U6 small nuclear RNA
associated (S. cerevisiae)
Hs.515255 chr19p13.11 71 0
226604_at TMTC3 transmembrane and tetratricopeptide repeat
containing 3
Hs.331268 chr12q21.32 71 0
220139_at DNMT3L DNA (cytosine-5-)-methyltransferase 3-like Hs.592165 chr21q22.3 70 0
206269_at GCM1 glial cells missing homolog 1 (Drosophila) Hs.28346 chr6p21-p12 69 0
203743_s_at TDG thymine-DNA glycosylase Hs.584809 chr12q24.1 69 0
219010_at C1orf106 chromosome 1 open reading frame 106 Hs.518997 chr1q32.1 69 0
225021_at ZNF532 zinc finger protein 532 Hs.529023 chr18q21.32 69 0
205524_s_at HAPLN1 hyaluronan and proteoglycan link protein 1 Hs.591758 chr5q14.3 68 0
206548_at FLJ23556 hypothetical protein FLJ23556 chr10q26.11 66 0
202800_at SLC1A3 solute carrier family 1 (glial high affinity
glutamate transporter), member 3
Hs.481918 chr5p13 65 0
229699_at Hs.61558 CDNA FLJ45384 fis, clone BRHIP3021987 Hs.61558 65 0
229830_at Hs.376032 Transcribed locus Hs.535898 65 0
202308_at SREBF1 sterol regulatory element binding transcription
factor 1
Hs.592123 chr17p11.2 64 0
203219_s_at APRT adenine phosphoribosyltransferase Hs.28914 chr16q24 64 0
225078_at EMP2 epithelial membrane protein 2 Hs.531561 chr16p13.2 64 0
218180_s_at EPS8L2 EPS8-like 2 Hs.55016 chr11p15.5 63 0
201440_at DDX23 DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 Hs.130098 chr12q13.12 62 0
201236_s_at BTG2 BTG family, member 2 Hs.519162 chr1q32 62 0
218721_s_at C1orf27 chromosome 1 open reading frame 27 Hs.371210 chr1q25 61 0
223062_s_at PSAT1 phosphoserine aminotransferase 1 Hs.494261 chr9q21.2 61 0
201613_s_at AP1G2 adaptor-related protein complex 1, gamma 2
subunit
Hs.343244 chr14q11.2 60 0
211986_at AHNAK AHNAK nucleoprotein (desmoyokin) Hs.502756 chr11q12.2 60 0
223449_at SEMA6A sema domain, transmembrane domain (TM),
and cytoplasmic domain, (semaphorin) 6A
Hs.156967 chr5q23.1 60 0
1567107_s_at TPM3 tropomyosin 4 Hs.631618 chr19p13.1 58 0
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modifiers cooperate with transcription factors and DNA repair
genes to regulate the whole gene expression profile in TE cells
(Figure 5). Disruption of this epigenetic regulatory circuit might
lead to alterations of the normal physiological functions. There-
fore, a comprehensive elucidation of this regulatory network would
be highly beneficial for understanding TE anomalies and for
improving assisted reproduction procedures. Moreover, a better
knowledge on the TE-specific genes and the transcriptional
networks operative in TE cells and day 3 embryos might led to
the identification of new biomarkers that might be used as
diagnostic tools to monitor the health, viability and competence of
embryos in assisted reproduction programs.
Limitations
As the day 3 embryos and the day 5 embryos used to isolate TE
cells were donated from infertile women who underwent IVF
treatments, the gene expression profiles could be have been
influenced by the controlled ovarian stimulation (COS) carried out
during IVF and thus they might not completely reflect the
physiological situation under natural cycles. Moreover, due to the
bioethics law that regulates the research on human embryos in
France, the number of embryos donated for research is smaller. In
view of these limitations, we optimized our technique to obtain
transcriptome data for each single embryo and trophectoderm
sample, respectively.
Materials and Methods
Specimen Collection and Processing
Human day 3 (post-fertilization) embryos and day 5 blastocysts
were donated for research by infertile couples undergoing IVF
treatment. All patients signed informed consent forms and the
protocol for collecting human embryos and TE was approved by
the Ethical Committee of the French National Agency of
Biomedicine.
Day 3 embryos. 9 embryos from 6 different couples were
used for microarray analyses (n=6) and qRT-PCR validation
(n=3). Day 3 embryos were all 6–8 cells with ,20% fragmen-
tation. Each embryo was individually transferred in a tube
containing extraction buffer and frozen at 280uC for subsequent
RNA extraction.
Trophectoderm biopsy. 8 day 5 blastocysts were used for
TE isolation for microarray analyses (n=5) and qRT–PCR
validation (n=3). Blastocysts were fully expanded with a well-
defined ICM and TE was scored according to Gardner [55]. After
removal of the zona pellucida, TE was mechanically dissected
from ICM. All TE samples were immediately transferred in tubes
containing RLT lysis buffer and frozen at 280uC.
Mature MII oocytes and hESCs. After informed consent,
unfertilized MII oocytes were collected 24 or 48 hours post-
insemination as previously described [56]. Briefly, three pools of
16 MII oocytes (6 patients), 21 MII oocytes (8 patients) and 24 MII
Table 2. Cont.
Probesets Gene Name Gene Title UniGene
Chromosomal
Location
Fold
Change FDR (%)
208659_at CLIC1 chloride intracellular channel 1 Hs.414565 chr6p22.1-p21.2 57 0
202546_at VAMP8 vesicle-associated membrane protein 8
(endobrevin)
Hs.534373 chr2p12-p11.2 57 0
227042_at LOC150223 hypothetical protein LOC150223 Hs.355952 chr22q11.21 57 0
202625_at LYN v-yes-1 Yamaguchi sarcoma viral related
oncogene homolog
Hs.651186 chr8q13 56 0
235436_at BE503800 55 0
223839_s_at Hs.597496 PRO1933 Hs.597496 55 0
202830_s_at SLC37A4 solute carrier family 37 (glycerol-6-phosphate
transporter), member 4
Hs.132760 chr11q23.3 54 0
228834_at TOB1 transducer of ERBB2, 1 Hs.649528 chr17q21 54 0
210589_s_at GBA glucosidase, beta; acid (includes
glucosylceramidase)
Hs.282997 chr1q21 53 0
208683_at CAPN2 calpain 2, (m/II) large subunit Hs.350899 chr1q41-q42 53 0
201428_at CLDN4 claudin 4 Hs.647036 chr7q11.23 52 0
217775_s_at RDH11 retinol dehydrogenase 11 (all-trans/9-cis/11-cis) Hs.226007 chr14q24.1 51 0
208613_s_at FLNB filamin B, beta (actin binding protein 278) Hs.476448 chr3p14.3 49 0
230204_at AU144114 49 0
209710_at GATA2 GATA binding protein 2 Hs.367725 chr3q21.3 48 0
215464_s_at TAX1BP3 Tax1 (human T-cell leukemia virus type I) binding
protein 3
Hs.12956 chr17p13 47 0
1559266_s_at FLJ45187 hypothetical protein LOC387640 Hs.350848 chr10p12.31 47 0
202090_s_at UQCR ubiquinol-cytochrome c reductase, 6.4 kDa
subunit
Hs.534521 chr19p13.3 47 0
209652_s_at PGF placental growth factor, vascular endothelial
growth factor-related protein
Hs.252820 chr14q24-q31 47 0
232164_s_at EPPK1 epiplakin 1 Hs.200412 chr8q24.3 47 0
doi:10.1371/journal.pone.0039306.t002
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for conventional IVF for tubal infertility or for ICSI for male
infertility were used for microarray analyses and qRT-PCR
validation. The three hESC lines (HD83, HD90 and HD129) were
derived by our group. Briefly, derivation of these lines was carried
out using mechanical extraction of the inner cell mass [57]. The
culture medium used for hESC derivation and culture consisted of
80% KO-DMEM, 20% Knockout serum replacement (KO-SR),
0.1 mM non-essential amino acids, 2 mM L-Glutamine, 0.5 mM
b-mercaptoethanol and 10 ng/mL of bFGF. Passaging was
performed mechanically by cutting the colony using a #15 scalpel
under microscope. Mitotically inactivated (by irradiation) human
foreskin fibroblasts (HFF) were used as feeder cells. HFFs were
cultured in 85% DMEM, 15% FBS. HD83, HD90 and HD129
hESC lines were used for microarray analyses and HD90, HD129
and HS181 (imported from the Karolinska Institute (Stockholm,
Sweden)) hESC lines were used for qRT–PCR validation.
RNA extraction. The RNeasy Micro kit (Qiagen) was used to
isolate total RNA from TE samples and the Picopure RNA
isolation kit (Arcturus Reagents/Molecular Devices, KIT0204,
USA) for day 3 embryos, according to the manufacturers’
recommended protocols. The quantity and purity of the total
RNAs were determined by using a NanoDropH ND-1000
spectrophotometer (NanoDrop ND-Thermo Fisher Scientific,
Wilmington, DE, USA) and their integrity by using the Agilent
2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, http://
www.agilent.com).
Complementary RNA (cRNA) Preparation and Microarray
Processing
Total day 3 embryo RNA samples (from 450 pg to 855 pg) were
subjected to three rounds of linear amplification and total TE
RNA samples (between 50 and 100 ng) were twice amplified to
Figure 4. Differential expression of apoptosis and stemness-related genes in day 3 embryos and TE samples. (A) Histograms show the
microarray signal values for apoptosis-related genes in day 3 embryos (black) and TE samples (white). (B) The mean expression level of 48 stemness
genes in six day 3 embryos and five TE samples was plotted on a logarithmic scale in a radar graph. Asterisks indicate a statistically significant
difference (P,0.05) between TE and day 3 embryos (Mann-Whitney test).
doi:10.1371/journal.pone.0039306.g004
Figure 5. Up-regulated genes that are related to the NANOG pathway, or to metabolic and epigenetic functions in day 3 human
embryos and TE samples. (A) The interaction network was generated with the Ingenuity software and shows that many genes from the NANOG
pathway are up-regulated (red) in day 3 embryos. (B) Top-ranked functional networks in which are involved transcription factors (GATA2 and GATA3),
or genes that regulate steroidogenesis (including HSD1B3), DNA repair (TDG and BRCA1) or epigenetic modifications (including DNMT3L) and that are
up-regulated in TE samples. The color intensity indicates their degree of up-regulation. Uncolored genes were identified as not differentially
expressed by our analysis, but were, nevertheless, integrated into the computationally generated networks on the basis of the evidence stored in the
IPA knowledge memory indicating a relevance to this network. In each network, nodes indicate genes, a plain line indicates direct interaction, a
dashed line indicates indirect interaction; a line without arrowhead indicates binding only; a line with an arrowhead indicates ‘‘acts on’’.
doi:10.1371/journal.pone.0039306.g005
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HG-U133 plus 2.0 GeneChip arrays (Affymetrix, Santa Clara,
CA, USA) as described in [9] and following the standard
Affymetrix instructions. Briefly, RNA was amplified from individ-
ual human embryos using the RiboAmpH HS Kit according to
manufacturer’s instructions (Arcturus Bioscience). During the first
strand synthesis reaction, cDNA that incorporates a T7 promoter
sequence is produced. This cDNA was then used as a template for
the in vitro-transcription reaction driven by the T7 promoter to
synthesize antisense RNA (aRNA), which was used as input for the
second round of amplification. cRNA was then transcribed into
cDNA and the T7 promoter was used to drive the second round of
in vitro transcription. The double-stranded cDNA was then
subjected to three rounds of linear amplification. The amplified
aRNA was labeled with biotin using the Turbo Labeling Kit
(Arctutus) and fragmented. Finally, fifteen micrograms of each
labeled sample were hybridized to the HG-U133plus2 GeneChip
array (Affymetrix). The microarray data were obtained in
agreement with the Minimal Information about Microarray
Experiment (MIAME) recommendations [58]. All data are
accessible at the US National Center for Biotechnology Informa-
tion, Gene Expression Omnibus (GEO) repository http://www.
ncbi.nlm.nih.gov/geo through the provisional accession series
number GSE33025.
Data Processing and Visualization
After image processing using the Affymetrix Microarray Suite
5.0, the cell files were analyzed using the Affymetrix Expression
Console software and normalized with the MAS5 algorithm by
scaling each array to a target value of 100 using the global scaling
method to obtain an intensity value signal for each probe set. Gene
annotation was performed using NetAffx (http://www.affymetrix.
com; March 2009). Genes with significant differential expression
profiles were identified using the two-class Significance Analysis of
Microarray (SAM) algorithm (http://www-stat.stanford.edu/
,tibs/SAM/) with the Wilcoxon test and sample label permuta-
tion (n=300). Briefly, the algorithm assigns a score to each gene
based on differences in expression between conditions relative to
the standard deviation of repeated measurements. The false
discovery rate (FDR) is determined using permutations of the
repeated measurements to estimate the percentage of genes
identified by chance. The algorithm was applied to each dataset
separately using FDR,1%. Subsequently, only the genes marked
as significantly up-regulated or down-regulated were considered as
differentially expressed in TE or embryos compared with the other
samples. For hierarchical clustering, data were log-transformed,
median-centered and processed with the CLUSTER and TREE-
VIEW software packages [59]. To cluster the samples according to
the similarity of their gene expression patterns, we performed an
unsupervised principal component analysis (PCA) with the RAGE
bioinformatics platform [http://rage.montp.inserm.fr/] to project
samples onto three-dimensional spaces that were further visualized
to see the constellation of all samples using all the detected genes.
The expression of selected genes in the panel of samples that
includes germinal, stem cells and adult tissues, were retrieved
through our ‘‘Amazonia!’’ database (http://amazonia.montp.
inserm.fr/). The Ingenuity Pathways Analysis (IPA) system
(Ingenuity Systems, Redwood City, CA, USA) was used to identify
networks related to the genes that were differentially expressed in
day 3 embryos and TE samples.
Gene Ontologies (GO) Classification
Gene Ontology (GO) annotation analysis was carried out using
the Fatigo+ tool http://babelomics.bioinfo.cipf.es [60] to identify
biologically relevant themes among the genes that were differen-
tially expressed in day 3 embryos and TE cells. Briefly, Fatigo+
performs a functional enrichment analysis by comparing two lists
of genes by means of the Fisher’s Exact Test. Gene modules used
in the test are defined in different ways that include functional
criteria (GO, KEGG, Biocarta, etc.). Also user-defined gene
modules can be imported and used for functional enrichment.
Validation of Microarray Data by Quantitative RT–PCR
Amplification
Gene expression profiles derived from microarray analyses were
confirmed quantitatively by real-time qRT-PCR analysis using
RNAs from three TE samples, three day 3 embryos, three MII
oocytes and three hESC samples. The primer sequences are shown
in Table S3. Briefly, cDNA was reverse transcribed following the
manufacturer’s instructions using 500 ng of total RNA in a 20 ml
reaction that contained Superscript II (Invitrogen), oligo dT
primer, dNTP mixture, MgCl2 and RNase inhibitor. Aliquots of
cDNA (1/25 of the RT reaction) were diluted in 50 ml reaction
volume. Q-PCR was performed using a LightCycler 480
apparatus with the LC480 SYBR Green I Master kit (Roche
Diagnostics, Mannheim, Germany) containing 2 ml cDNA and
0.6 mMol primers in a total volume of 10 ml. After 10 min of
activation at 95uC, cycling conditions were 10 s at 95uC, 30 s at
63uC and 1 s at 72uC for 50 cycles. Gene expression levels were
normalized to GAPDH using the following formula 100/2
DDCt
where DDCt=DCt unknown - DCt positive control. Statistical
comparisons were carried out using the Student’s t test and the
SPSS software. P values less than or equal to 0.05 were considered
significant.
Supporting Information
Figure S1 Scatter plots showing the comparative distri-
bution of transcripts in mature MII oocytes, day 3
embryos, TE and hESC samples. Each sample was plotted
against all the other samples to visualize expression variations. The
blue areas highlight a greater than two-fold gene expression
difference (up-regulated) between the X-axis and Y-axis samples.
The orange areas indicate a greater than two-fold gene expression
difference (down-regulated) between the X-axis and Y-axis
samples. The yellow areas highlight a 0.5- to 2-fold gene
expression difference between the X-axis and Y-axis samples.
For each couple of samples, the Pearson’s correlation coefficient
was computed (r).
(TIF)
Figure S2 Quantitative RT–PCR validation of the mi-
croarray results: All qRT–PCR results were normalized to the
expression of GAPDH in each sample and are the mean 6 SEM of
individual day 3 embryos (n=3), TE (n=3), pooled MII oocyte
(n=3) and hESC (n=3) samples analyzed in duplicate. *P,0.05
was considered significant
(TIF)
Figure S3 IPA results showing the network of DNA
repair genes that are up-regulated in TE samples from
day 5 human blastocysts and day 3 embryos.
(TIF)
Figure S4 Venn diagram representing the number of
genes in each comparison and the overlaps between the
three main comparison groups. The day 3 embryo/MII
oocyte/hESC signatures were defined as the intersection of the
day 3 embryo signature (genes over-expressed in day3 embryos
compared with TE samples; 1714 genes), the MII oocytes
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cells; 4444 genes ) and the hESC signature (genes up-regulated in
hESC compared to TE samples, 5502 genes). The TE/MII
oocyte/hESC signature were defined as the intersection of the TE
signature (genes over-expressed in TE compared with day 3
embryos; 2196 genes), the MII oocyte signature (genes over-
expressed in MII oocytes compared with day 3 embryos; 3198
genes ) and the hESC signature (genes over-expressed in hESCs
compared with day 3 embryos; 8584 genes). The comparison
between categories were generated by using the SAM software
with a fold change $2 and FDR ,1%.
(TIF)
Figure S5 Expression of selected genes, which were up-
regulated either in TE cells (HSD3B1, HSD17B1, FDX1,
PTGS and DNMT3L) or day 3 embryos (NANOG,
MBD3L2, ZSCAN4, RFPL2 and DPPA2), and of beta-Actin
in the panel of samples that includes MII oocytes and
hESCs using the Amazonia! gene atlas explorer (http://
www.amazonia.transcriptome.eu). Abbreviations: hESC,
human embryonic stem cell; hiPS, human induced pluripotent
stem cells; TE, Trophectoderm; hFF, human foreskin fibroblasts;
CNS, central nervous system; DT, digestive tract; H & L, Heart
and muscle; HEMATO, various hematopoietic tissues; End,
Endometrium; PL, placenta.
(TIF)
Table S1 List of the 1,714 transcripts specific to the day 3
embryo molecular signature.
(XLS)
Table S2 List of the 2,196 transcripts specific to the TE
molecular signature.
(XLS)
Table S3 Primer pairs used for validating the array data by
qRT-PCR.
(DOC)
Table S4 List of the transcripts included in the signatures
analyzed in this manuscript. (a) Day 3 embryo/MII oocyte
signature, (b) Day 3 embryo/hESC signature, (c) TE/MII oocyte
signature, (d) TE/hESC signature, (e) specific day 3 embryo
signature and (f) specific TE signature.
(XLS)
Table S5 List of the 104 genes that were up-regulated both in
TE cells obtained by hESCs differentiation in the presence of
BMP4 for 10 days (transcriptome analysis by Marchand et al, [29])
and in TE cells isolated from day 5 embryos (this study).
(XLS)
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